Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?-Reference-Cited by-同舟云学术

Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?

Published:2021-07-15 Issue:11 Volume:20 Page:1369-1371
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Koopman Jan Pieter R.¹^ORCID,Driciru Emmanuella²,Roestenberg Meta³

Affiliation:

1. Department of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands

2. Immunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda

3. Department of Parasitology and Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands

Funder

European Union’s Horizon 2020 research and innovation programme

MRC/UVRI Uganda Research Unit

UK Medical Research Council

UK department for International Development

Wellcome

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1951244

Reference20 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. The Human Hookworm Vaccine

3. Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination

4. Experimental infection of human volunteers

5. Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis;Nature Medicine;2024-08-02

2. Antibiotic Chemoprophylaxis for Leptospirosis: Previous Shortcomings and Future Needs;Tropical Medicine and Infectious Disease;2024-07-02

3. Vaccine value profile for schistosomiasis;Vaccine;2024-07

4. Transmission Modelling for Human Non-Zoonotic Schistosomiasis Incorporating Vaccination: Guiding Decision- and Policymaking;Parasitologia;2024-04-15

5. Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasis;2024-04-13